Log In
Print this Print this

Dodecal (F8-IL12)

  Manage Alerts
Collapse Summary General Information
Company Philogen S.p.A.
DescriptionImmunocytokine consisting of the vascular targeting antibody F8 fused to the heterodimeric cytokine interleukin-12 (IL12)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today